Jinling Pharmaceutical Co Ltd Financial Flexibility Index
Jinling Pharmaceutical Co Ltd financial flexibility index. Jinling Pharmaceutical Co Ltd (000919) has a Financial Flexibility Index of 0.07x as of September 2025. Free cash flow of CN¥86.57 Million (operating CF CN¥74.01 Million minus capex CN¥12.56 Million) represents 0% of total liabilities (CN¥1.18 Billion). See how much free cash does Jinling Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jinling Pharmaceutical Co Ltd (1999–2024)
Financial flexibility index of Jinling Pharmaceutical Co Ltd from 1999 to 2024. Historical Financial Flexibility Index trend for Jinling Pharmaceutical Co Ltd across 26 annual periods. Check 000919 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Jinling Pharmaceutical Co Ltd Financial Flexibility Index by Year (1999–2024)
Jinling Pharmaceutical Co Ltd financial flexibility index by year from 1999 to 2024. Year-by-year free cash flow to debt coverage for Jinling Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Jinling Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.29x | CN¥355.82 Million | CN¥154.19 Million | CN¥1.24 Billion | ▼ -28.1% |
| 2023 | 0.40x | CN¥345.18 Million | CN¥158.92 Million | CN¥865.58 Million | ▼ -35.9% |
| 2022 | 0.62x | CN¥570.23 Million | CN¥260.59 Million | CN¥916.30 Million | ▲ +24.9% |
| 2021 | 0.50x | CN¥454.79 Million | CN¥292.03 Million | CN¥913.10 Million | ▼ -29.7% |
| 2020 | 0.71x | CN¥602.87 Million | CN¥311.46 Million | CN¥850.43 Million | ▼ -12.1% |
| 2019 | 0.81x | CN¥591.56 Million | CN¥465.85 Million | CN¥733.62 Million | ▼ -9.7% |
| 2018 | 0.89x | CN¥570.25 Million | CN¥433.83 Million | CN¥638.90 Million | ▲ +40.6% |
| 2017 | 0.63x | CN¥509.90 Million | CN¥443.11 Million | CN¥803.11 Million | ▲ +151.0% |
| 2016 | 0.25x | CN¥203.60 Million | CN¥96.15 Million | CN¥804.90 Million | ▼ -26.1% |
| 2015 | 0.34x | CN¥316.76 Million | CN¥212.45 Million | CN¥925.73 Million | ▼ -23.8% |
| 2014 | 0.45x | CN¥391.03 Million | CN¥299.89 Million | CN¥871.24 Million | ▼ -21.1% |
| 2013 | 0.57x | CN¥415.26 Million | CN¥271.21 Million | CN¥729.94 Million | ▼ -0.9% |
| 2012 | 0.57x | CN¥420.88 Million | CN¥232.12 Million | CN¥733.12 Million | ▲ +42.5% |
| 2011 | 0.40x | CN¥255.03 Million | CN¥172.82 Million | CN¥633.01 Million | ▼ -19.7% |
| 2010 | 0.50x | CN¥273.29 Million | CN¥177.81 Million | CN¥544.47 Million | ▼ -29.5% |
| 2009 | 0.71x | CN¥285.01 Million | CN¥188.41 Million | CN¥400.59 Million | ▼ -29.5% |
| 2008 | 1.01x | CN¥327.38 Million | CN¥305.26 Million | CN¥324.25 Million | ▲ +202.7% |
| 2007 | 0.33x | CN¥139.03 Million | CN¥118.06 Million | CN¥416.86 Million | ▼ -31.8% |
| 2006 | 0.49x | CN¥161.59 Million | CN¥138.50 Million | CN¥330.39 Million | ▼ -6.0% |
| 2005 | 0.52x | CN¥145.90 Million | CN¥109.29 Million | CN¥280.42 Million | ▼ -27.7% |
| 2004 | 0.72x | CN¥232.28 Million | CN¥159.81 Million | CN¥322.83 Million | ▼ -15.7% |
| 2003 | 0.85x | CN¥218.59 Million | CN¥161.86 Million | CN¥256.06 Million | ▲ +8.7% |
| 2002 | 0.79x | CN¥232.99 Million | CN¥130.36 Million | CN¥296.79 Million | ▼ -4.8% |
| 2001 | 0.82x | CN¥252.77 Million | CN¥92.49 Million | CN¥306.54 Million | ▼ -63.6% |
| 2000 | 2.27x | CN¥365.80 Million | CN¥231.31 Million | CN¥161.37 Million | ▲ +212.0% |
| 1999 | 0.73x | CN¥111.34 Million | CN¥39.77 Million | CN¥153.24 Million | — |